Neoleukin Therapeutics Inc (NASDAQ:NLTX)
| 0.625 Delayed Data As of Mar 24 |  +0.0002 / +0.03%Today’s Change | 0.38 Today|||52-Week Range 2.32 | +22.79% Year-to-Date |
Institutional investors control 40.58% of the outstanding shares in NLTX. This represents a greater percentage of ownership than at almost any other company in the Biotechnology industry. Additionally, during the quarter ended June 2019, these large investors purchased a net $1.5 million shares.
| Mutual fund holders | 7.85% |
| Other institutional | 32.73% |
| Individual stakeholders | 28.22% |
Largest Quarterly Institutional
Transactions
Latest Institutional Activity
| 12/31/2022 | LYNX1 CAPITAL MANAGEMENT LP Bought 2.3 Million shares of Neoleukin Therapeutics In... |
| 12/31/2022 | BANK OF AMERICA, NA (PRIVATE BAN... Bought 1.4 Million shares of Neoleukin Therapeutics In... |
| 12/31/2022 | JANE STREET CAPITAL LLC Bought 60.7 Thousand shares of Neoleukin Therapeutics In... |
Top 10 Owners of Neoleukin Therapeutics Inc
| Stockholder | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP | 8.97% | 3,821,740 | 1,922,335 | 0 | 0.00% |
| Lynx1 Capital Management LP | 5.38% | 2,291,133 | 1,152,440 | +2,291,133 | -- |
| Redmile Group LLC | 4.35% | 1,850,566 | 930,835 | -1,586,369 | -46.16% |
| Bank of America, NA (Private Bank... | 3.78% | 1,611,563 | 810,616 | +1,442,092 | +850.94% |
| Millennium Management LLC | 3.73% | 1,587,267 | 798,395 | -108,116 | -6.38% |
| Renaissance Technologies LLC | 2.80% | 1,193,447 | 600,304 | -248,620 | -17.24% |
| The Vanguard Group, Inc. | 2.35% | 1,002,404 | 504,209 | -9,590 | -0.95% |
| BlackRock Fund Advisors | 1.39% | 589,892 | 296,716 | -277,600 | -32.00% |
| Barclays Bank Plc (Private Bankin... | 1.06% | 452,250 | 227,482 | 0 | 0.00% |
| Morgan Stanley & Co. LLC | 0.77% | 329,516 | 165,747 | -7,774 | -2.30% |
Top 10 Mutual Funds Holding Neoleukin Therapeutics Inc
| Mutual fund | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| Pictet - Biotech | 3.31% | 1,409,092 | 708,773 | -72,742 | -4.91% |
| Vanguard Total Stock Market Index... | 1.16% | 493,540 | 248,251 | 0 | 0.00% |
| Vanguard Extended Market Index Fu... | 1.12% | 478,838 | 240,856 | 0 | 0.00% |
| Nomura Asset World Genome Technol... | 0.80% | 339,233 | 170,634 | -15,878 | -4.47% |
| Fidelity Extended Market Index Fu... | 0.41% | 174,634 | 87,841 | 0 | 0.00% |
| Bridgeway Ultra Small Company Mar... | 0.18% | 75,000 | 37,725 | 0 | 0.00% |
| iShares Tr. - Micro Cap ETF | 0.17% | 73,634 | 37,038 | 0 | 0.00% |
| iShares Core S&P Total US Stock M... | 0.12% | 50,877 | 25,591 | +114 | +0.22% |
| Fidelity Total Market Index Fund | 0.11% | 48,248 | 24,269 | 0 | 0.00% |
| Fidelity Series Total Market Inde... | 0.09% | 36,968 | 18,595 | 0 | 0.00% |